Both probes revealed a strong association between elevated Nrf2 expression and poorer survival outcomes in lung cancer patients at the AJCC T1 and T2 stage, regardless of smoking status or histological subtypes (Figure2A, left, and data not shown). This evidence concerns the gene NFE2L2 and lung carcinoma.